TriStar Centennial Heart and Vascular Center performs first MEMO 4D implant
TriStar Centennial Heart and Vascular Center is continuing its long-standing commitment of offering the latest in cardiovascular surgical treatment options by implanting the first MEMO 4D semi-rigid mitral annuloplasty ring in the world. Led by cardiovascular surgeon, Dr. Sreekumar Subramanian, the cardiovascular surgical team at TriStar Centennial performed the first implant on Friday, June 1, 2018. The implant now comes in larger ring sizes, allowing surgeons to treat a broader range of patients who suffer from mitral valve regurgitation.
Mitral valve regurgitation is a condition where the mitral valve in the heart doesn’t close properly causing the blood to flow backward within the heart. Symptoms can include a heart murmur, shortness of breath, fatigue and heart palpitations. Some cases do not require any treatment, but if it is severe enough, surgery to repair or replace the valve might be required.
“MEMO 4D simplifies and standardizes complex mitral valve repair, facilitates minimally invasive surgical approaches and preserves the mobility of the mitral valve leaflets,” said Dr. Sreekumar Subramanian, TriStar Heart & Vascular Center cardiovascular surgeon. “The new, larger sizes allow us to treat more patients and pathologies while providing the potential to further improve patient outcomes. With MEMO 4D, surgeons can optimize mitral repair procedures rather than replacing the entire mitral valve.”
LivaNova, the medical device company that produces the larger MEMO 4D, is the only company to offer larger ring sizes which helps in the treatment of severe mitral regurgitation like Barlow’s disease or enlarged annuli.
“We are excited to be the first hospital to offer this new device that can help treat more patients diagnosed with mitral regurgitation,” said TriStar Centennial Medical Center Chief Executive Officer, Scott Cihak. “Our multidisciplinary team of cardiologists and cardiovascular surgeons are committed to offering the latest in cardiovascular surgical treatment options that will help to ensure the best possible outcomes for patients.”
For more information about MEMO 4D and to learn about the various treatment options available for patients suffering from mitral valve disease, please visit www.tristarcardiovascularsurgery.com or call 615.342.6900.
